MHRA Appoints CHM Vice Chair

From DCAT Value Chain Insights (VCI)

By Regulatory News posted 01-20-2015 09:09


The UK's Medicines and Healthcare Products Agency (MHRA) has appointed Dr. Angela Thomas has been appointed as vice-chair of the Commission on Human Medicines (CHM). She replaces Professor Ian Weller who retired from the position and from CHM on December 31, 2014.

The CHM advises on matters relating to safety, quality, and the efficacy of medicines as well as the collection of adverse drug reactions.

Dr. Thomas is a consultant pediatric hematologist at the Royal Hospital for Sick Children in Edinburgh, a fellow of the Royal College of Physicians in Edinburgh, a former president of the British Society for Hematology and has been on the CHM since 2005, where she chairs the Clinical Trials, Biologicals & Vaccines Expert Advisory Group. She has also served as a member and chaired many scientific and medical committees in the UK and Europe.

Source: MHRA


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription